Finance

Lists
543828:BOM
Sudarshan Pharma Industries Ltd
36,25 ₹
0,00%
(0,00) 1D
16 հոկ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543828...
Open
35,20 ₹
High
36,99 ₹
Low
35,06 ₹
Mkt. cap
9,22 մլրդ
Avg. vol.
409,20 հզր
Volume
72,00 հզր
P/E ratio
34,94
52-wk high
42,79 ₹
52-wk low
18,50 ₹
EPS
1,04 ₹
No. of employees
64
Open
35,20 ₹
High
36,99 ₹
Low
35,06 ₹
Mkt. cap
9,22 մլրդ
Avg. vol.
409,20 հզր
Volume
72,00 հզր
P/E ratio
34,94
52-wk high
42,79 ₹
52-wk low
18,50 ₹
EPS
1,04 ₹
No. of employees
64
News stories
From web sources and news partners
About Sudarshan Pharma Industries Ltd
CEO-
Employees64
Founded2008
Headquarters-
SectorSpeciality chemicals
Last report
12 օգս, 2026 թ.
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
1,74 մլրդ / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,69 մլրդ
1,68 մլրդ
2,21 մլրդ
1,74 մլրդ
Cost of goods sold
1,52 մլրդ
1,48 մլրդ
1,90 մլրդ
1,50 մլրդ
Cost of revenue
1,52 մլրդ
1,48 մլրդ
1,90 մլրդ
1,50 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17,78 մլն
19,74 մլն
33,01 մլն
20,68 մլն
Operating expense
82,51 մլն
102,47 մլն
106,15 մլն
101,78 մլն
Total operating expenses
1,61 մլրդ
1,58 մլրդ
2,01 մլրդ
1,60 մլրդ
Operating income
83,02 մլն
99,60 մլն
200,65 մլն
144,93 մլն
Other non operating income
18,63 մլն
15,18 մլն
-49,24 մլն
12,20 մլն
EBT including unusual items
42,28 մլն
51,98 մլն
157,04 մլն
75,05 մլն
EBT excluding unusual items
42,28 մլն
51,98 մլն
146,84 մլն
75,05 մլն
Income tax expense
3,56 մլն
10,50 մլն
43,12 մլն
18,96 մլն
Effective tax rate
8,41%
20,20%
27,46%
25,26%
Other operating expenses
55,72 մլն
73,62 մլն
62,22 մլն
67,03 մլն
Net income
41,83 մլն
43,57 մլն
107,26 մլն
58,55 մլն
Net profit margin
2,48%
2,59%
4,86%
3,36%
Earnings per share
-
-
-
-
Interest and investment income
-
-
20,21 մլն
-
Interest expense
-59,38 մլն
-62,79 մլն
-46,82 մլն
-82,07 մլն
Net interest expenses
-59,38 մլն
-62,79 մլն
-26,61 մլն
-82,07 մլն
Depreciation and amortization charges
9,01 մլն
9,11 մլն
10,93 մլն
14,06 մլն
EBITDA
91,95 մլն
102,17 մլն
206,78 մլն
154,40 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps